The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Open accessAbstract
The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor best known for mediating the toxicity of dioxin. Environmental factors are believed to contribute to the increased prevalence of autoimmune diseases, many of which are due to the activity of T(H)17 T cells, a new helper T-cell subset characterized by the production of the cytokine IL-17. Here we show that in the CD4+ T-cell lineage of mice AHR expression is restricted to the T(H)17 cell subset and its ligation results in the production of the T(H)17 cytokine interleukin (IL)-22. AHR is also expressed in human T(H)17 cells. Activation of AHR by a high-affinity ligand during T(H)17 cell development markedly increases the proportion of T(H)17 T cells and their production of cytokines. CD4+ T cells from AHR-deficient mice can develop T(H)17 cell responses, but when confronted with AHR ligand fail to produce IL-22 and do not show enhanced T(H)17 cell development. AHR activation during induction of experimental autoimmune encephalomyelitis causes accelerated onset and increased pathology in wild-type mice, but not AHR-deficient mice. AHR ligands may therefore represent co-factors in the development of autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, many phenotypes of Ahr mutant models such as altered hepatovascular development and impaired immune function, do not appear to be directly related to TCDD toxicity or adaptive metabolism (Quintana et al., 2008; Stockinger et al., 2014; Veldhoen et al., 2008; Walisser et al., 2005)”
From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Veldhoen et al., 2008
In the citing paper
“it was demonstrated that expression of IL-22 requires the AhR (Martin et al., 2009; Veldhoen et al., 2008).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Veldhoen et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P. A., Kasman, I. M., Eastham‐Anderson, J., Wu, J., & Ouyang, W. (2006) · Nature · doi:10.1038/nature05505 · Cited by 1,888
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Immune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor
Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S. T., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1995) · Science · doi:10.1126/science.7732381 · Cited by 1,075
Hirota, K., Yoshitomi, H., Hashimoto, M., Maeda, S., Teradaira, S., Sugimoto, N., Yamaguchi, T., Nomura, T., Ito, H., Nakamura, T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071397 · Cited by 937
Self-citationSchmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C., & Bradfield, C. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6731 · Cited by 902
AH RECEPTOR SIGNALING PATHWAYS
Schmidt, J. V., & Bradfield, C. A. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.55 · Cited by 899
Cited by
Sorted by citations
Items 401–500 of 1,001
The aryl hydrocarbon receptor: structure, signaling, physiology and pathology
Coumoul, X., Barouki, R., Esser, C., Haarmann‐Stemmann, T., Lawrence, B. P., Lehmann, J., Moura‐Alves, P., Murray, I. A., Opitz, C. A., Perdew, G. H., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02500-8 · Cited by 111
Platzer, B., Richter, S., Kneidinger, D., Waltenberger, D., Woisetschläger, M., & Strobl, H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802997 · Cited by 106
Functional Flexibility of Intestinal IgA – Broadening the Fine Line
Slack, E. M. C., Balmer, M. L., Fritz, J. H., & Hapfelmeier, S. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00100 · Cited by 103
IL‐22 and inflammation: Leukin' through a glass onion
Zenewicz, L. A., & Flavell, R. A. (2008) · European Journal of Immunology · doi:10.1002/eji.200838655 · Cited by 104
Regulation of bone by the adaptive immune system in arthritis
Okamoto, K., & Takayanagi, H. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3323 · Cited by 107
From genes to function: the next challenge to understanding multiple sclerosis
Fugger, L. H., Friese, M. A., & Bell, J. I. (2009) · Nature reviews. Immunology · doi:10.1038/nri2554 · Cited by 105
Regulation of intestinal homeostasis by innate and adaptive immunity
Kayama, H., & Takeda, K. (2012) · International Immunology · doi:10.1093/intimm/dxs094 · Cited by 108
The complex biology of aryl hydrocarbon receptor activation in cancer and beyond
Opitz, C. A., Holfelder, P., Prentzell, M. T., & Trump, S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115798 · Cited by 109
Interactions between neutrophils and T-helper 17 cells
Fan, X., Shu, P., Wang, Y., Ji, N., & Zhang, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1279837 · Cited by 103
Structure and Dimerization Properties of the Aryl Hydrocarbon Receptor PAS-A Domain
Wu, D., Potluri, N., Kim, Y., & Rastinejad, F. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00698-13 · Cited by 103
Morrison, P. J., Ballantyne, S. J., & Kullberg, M. C. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03454.x · Cited by 104
Hanieh, H. (2014) · BioMed Research International · doi:10.1155/2014/520763 · Cited by 106
IL-22, cell regeneration and autoimmunity
Nikoopour, E., Bellemore, S. M., & Singh, B. (2014) · Cytokine · doi:10.1016/j.cyto.2014.09.007 · Cited by 103
Estrogen, estrogen-like molecules and autoimmune diseases
Merrheim, J., Villegas, J. A., Wassenhove, J. V., Khansa, R., Berrih‐Aknin, S., Panse, R. L., & Dragin, N. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102468 · Cited by 102
Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus
Law, C., Wacleche, V. S., Cao, Y., Pillai, A., Sowerby, J. M., Hancock, B. L., Horisberger, A., Bracero, S., Skidanova, V., Li, Z., et al. (2024) · Nature · doi:10.1038/s41586-024-07627-2 · Cited by 104
Evidence for Ligand-Mediated Selective Modulation of Aryl Hydrocarbon Receptor Activity
Murray, I. A., Morales, J. L., Flaveny, C. A., DiNatale, B. C., Chiaro, C. R., Gowda, K., Amin, S., & Perdew, G. H. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.061788 · Cited by 104
Tissue-specific immunity for a changing world
Weisberg, S. P., Ural, B. B., & Färber, D. L. (2021) · Cell · doi:10.1016/j.cell.2021.01.042 · Cited by 104
Volpe, E., Touzot, M., Servant, N., Marloie-Provost, M.-A., Hupé, P., Barillot, E., & Soumelis, V. (2009) · Blood · doi:10.1182/blood-2009-05-223768 · Cited by 109
Liu, T., Peng, L., Yu, P.-W., Zhao, Y., Shi, Y., Mao, X., Chen, W., Cheng, P., Wang, T., Chen, N., et al. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9718-8 · Cited by 103
Zhang, S., Kim, K., Jin, U. H., Pfent, C. M., Cao, H., Amendt, B. A., Liu, X., Wilson-Robles, H. M., & Safe, S. H. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0548 · Cited by 100
Development, regulation and functional capacities of Th17 cells
Hirota, K., Martin, B., & Veldhoen, M. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-009-0187-y · Cited by 99
Self-citationThe obesity-related pathology and Th17 cells
Endo, Y., Yokote, K., & Nakayama, T. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2399-3 · Cited by 102
Castañeda, A. R., Pinkerton, K. E., Bein, K. J., Magaña-Méndez, A., Yang, H. T., Ashwood, P., & Vogel, C. F. A. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.04.020 · Cited by 102
Szelest, M., Walczak, K., & Plech, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031104 · Cited by 102
Bahman, F., Choudhry, K., Al‐Rashed, F., Al‐Mulla, F., Sindhu, S. T. A. K., & Ahmad, R. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1421346 · Cited by 106
The aryl hydrocarbon receptor: a rehabilitated target for therapeutic immune modulation
Polonio, C. M., McHale, K. A., Sherr, D. H., Rubenstein, D., & Quintana, F. J. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01172-x · Cited by 104
Sugimoto, S., Naganuma, M., Kiyohara, H., Arai, M., Ono, K., Mori, K., Saigusa, K., Nanki, K., Takeshita, K., Takeshita, T., et al. (2016) · Digestion · doi:10.1159/000444217 · Cited by 100
Immunoregulatory effects of HO-1: how does it work?
Soares, M. P., Marguti, I., Cunha, A., & Larsen, R. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.05.008 · Cited by 97
Zhang, L., Ma, J., Takeuchi, M., Usui, Y., Hattori, T., Okunuki, Y., Yamakawa, N., Kezuka, T., Kuroda, M., & Goto, H. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3993 · Cited by 99
The Current STATus of lymphocyte signaling: new roles for old players
Adamson, A. S., Collins, K., Laurence, A. D. J., & O’Shea, J. J. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.03.013 · Cited by 100
Regulatory T cells in autoimmune hepatitis: an updated overview
Longhi, M. S., Mieli‐Vergani, G., & Vergani, D. (2021) · Journal of Autoimmunity · doi:10.1016/j.jaut.2021.102619 · Cited by 100
A role for Th17 cells in the regulation of tertiary lymphoid follicles
Grogan, J. L., & Ouyang, W. (2012) · European Journal of Immunology · doi:10.1002/eji.201242656 · Cited by 99
Melhem, H., Kaya, B., Ayata, C. K., Hruz, P. L., & Niess, J. H. (2019) · Cells · doi:10.3390/cells8050450 · Cited by 96
Decoding IL-23 Signaling Cascade for New Therapeutic Opportunities
Pastor-Fernández, G., Mariblanca, I. R., & Navarro, M. N. (2020) · Cells · doi:10.3390/cells9092044 · Cited by 102
Kober, C., Roewe, J., Schmees, N., Roese, L., Roehn, U., Bader, B., Stoeckigt, D., Prinz, F., Gorjánácz, M., Roider, H. G., et al. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2023-007495 · Cited by 98
Hughes, T. L., Briercheck, E. L., Freud, A. G., Trotta, R., McClory, S., Scoville, S. D., Keller, K. A., Deng, Y., Cole, J. P., Harrison, N. R., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.042 · Cited by 103
A tale of two cytokines: IL-17 and IL-22 in asthma and infection
Manni, M. L., Robinson, K. M., & Alcorn, J. F. (2013) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2014.854167 · Cited by 96
Ghiboub, M., Verburgt, C. M., Sovran, B., Benninga, M. A., de Jonge, W. J., & Limbergen, J. V. (2020) · Nutrients · doi:10.3390/nu12092846 · Cited by 97
Immune responses of TLR5+ lamina propria dendritic cells in enterobacterial infection
Uematsu, S., & Akira, S. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0094-y · Cited by 97
Control of immune-mediated pathology via the aryl hydrocarbon receptor
Wheeler, M. A., Rothhammer, V., & Quintana, F. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r116.767723 · Cited by 95
Gut microbiota and central nervous system development
Principi, N., & Esposito, S. (2016) · Journal of Infection · doi:10.1016/j.jinf.2016.09.010 · Cited by 92
Contact dermatitis: from pathomechanisms to immunotoxicology
Martin, S. F. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01471.x · Cited by 97
Aryl hydrocarbon receptor is required for optimal B‐cell proliferation
Villa, M., Gialitakis, M., Tolaini, M., Ahlfors, H., Henderson, C. J., Wolf, C. R., Brink, R. A., & Stockinger, B. (2016) · The EMBO Journal · doi:10.15252/embj.201695027 · Cited by 92
Self-citationBilirubin suppresses Th17 immunity in colitis by upregulating CD39
Longhi, M. S., Vuerich, M., Kalbasi, A., Kenison, J. E., Yeste, A., Csizmadia, E., Vaughn, B. P., Feldbrügge, L., Mitshuhashi, S., Wegiel, B., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92791 · Cited by 94
Shen, P.-X., Li, X., Deng, S.-Y., Zhao, L., Zhang, Y., Deng, X., Han, B., Yu, J., Li, Y., Wang, Z., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103227 · Cited by 94
Aryl hydrocarbon receptor controls murine mast cell homeostasis
Zhou, Y., Tung, H.-Y., Tsai, Y., Hsu, S., Chang, H., Kawasaki, H., Tseng, H.-C., Plunkett, B., Gao, P., Hung, C., et al. (2013) · Blood · doi:10.1182/blood-2012-08-453597 · Cited by 97
Role of the aryl hydrocarbon receptor (AhR) in lung inflammation
Beamer, C. A., & Shepherd, D. M. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0391-7 · Cited by 99
Th17 cells: critical mediators of host responses to burn injury and sepsis
Rendón, J. L., & Choudhry, M. A. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0212083 · Cited by 95
MicroRNA-155 Confers Encephalogenic Potential to Th17 Cells by Promoting Effector Gene Expression
Hu, R., Huffaker, T. B., Kagele, D., Runtsch, M. C., Bake, E., Chaudhuri, A. A., Round, J. L., & O’Connell, R. M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300351 · Cited by 92
Functional modulation of AMP-activated protein kinase by cereblon
Lee, K. M., Jo, S., Kim, H., Lee, J., & Park, C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.005 · Cited by 94
Protein phosphatase 2A enables expression of interleukin 17 (IL-17) through chromatin remodeling
Apostolidis, S. A., Rauen, T., Hedrich, C. M., Tsokos, G. C., & Crispín, J. C. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.483743 · Cited by 91
Kurebayashi, Y., Nagai, S., Ikejiri, A., & Koyasu, S. (2013) · Genes to Cells · doi:10.1111/gtc.12039 · Cited by 93
Aryl hydrocarbon receptor: Its roles in physiology
Kou, Z., & Dai, W. H. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114428 · Cited by 94
Modulating AHR function offers exciting therapeutic potential in gut immunity and inflammation
Chen, Y., Wang, Y., Fu, Y., Yin, Y., & Xu, K. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01046-y · Cited by 92
Th17 cells in central nervous system autoimmunity
Sie, C., Korn, T., & Mitsdoerffer, M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.03.009 · Cited by 95
Kimura, A., & Kishimoto, T. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.10.004 · Cited by 91
The Immunoregulation of Th17 in Host against Intracellular Bacterial Infection
Li, Y., Wei, C., Xu, H., Jia, J., Wei, Z., Guo, R. H., Jia, Y., Wu, Y. H., Li, Y., Qi, X., et al. (2018) · Mediators of Inflammation · doi:10.1155/2018/6587296 · Cited by 96
Grunewald, M. E., Shaban, M. G., Mackin, S., Fehr, A. R., & Perlman, S. M. (2019) · Journal of Virology · doi:10.1128/jvi.01743-19 · Cited by 92
Breast Milk and Solid Food Shaping Intestinal Immunity
Parigi, S. M., Eldh, M., Larssen, P., Gabrielsson, S., & Villablanca, E. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00415 · Cited by 97
The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy
Zhang, S. J., Lei, P., Liu, X., Li, X., Walker, K., Kotha, L., Rowlands, C., & Safe, S. H. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0054 · Cited by 93
Th17-related cytokines: new players in the control of chronic intestinal inflammation
Monteleone, I., Pallone, F., & Monteleone, G. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-122 · Cited by 92
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
Rolla, S., Bardina, V., Mercanti, S. F. D., Quaglino, P., Palma, R. D., Gned, D., Brusa, D., Durelli, L., Novelli, F., & Clerico, M. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0813-463rr · Cited by 90
Chinen, I., Nakahama, T., Kimura, A., Nguyen, N., Takemori, H., Kumagai, A., Kayama, H., Takeda, K., Lee, S., Hanieh, H., et al. (2015) · International Immunology · doi:10.1093/intimm/dxv015 · Cited by 90
A tryptophan metabolite, kynurenine, promotes mast cell activation through aryl hydrocarbon receptor
Kawasaki, H., Chang, H. ‐., Tseng, H.-C., Hsu, S., Yang, S. ‐., Hung, C. ‐., Zhou, Y., & Huang, S. (2014) · Allergy · doi:10.1111/all.12346 · Cited by 91
TH17 cells in asthma and inflammation
Aujla, S. J., & Alcorn, J. F. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.02.002 · Cited by 93
Boutros, P. C., Yan, R., Moffat, I. D., Pohjanvirta, R., & Okey, A. B. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-419 · Cited by 90
Yang, J., Yang, X., Zou, H., Chu, Y., & Li, M. (2011) · Rheumatology · doi:10.1093/rheumatology/ker116 · Cited by 89
Dorhoi, A., & Kaufmann, S. H. E. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.10.002 · Cited by 90
Immunologic impact of the intestine in metabolic disease
Winer, D. A., Winer, S., Dranse, H. J., & Lam, T. K. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88879 · Cited by 95
Dietary Habits and Intestinal Immunity: From Food Intake to CD4+ TH Cells
Siracusa, F., Schaltenberg, N., Villablanca, E. J., Huber, S., & Gagliani, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03177 · Cited by 91
The microbiome: an integral player in immune homeostasis and inflammation in the respiratory tract
Perdijk, O., Azzoni, R., & Marsland, B. J. (2023) · Physiological Reviews · doi:10.1152/physrev.00020.2023 · Cited by 94
An atlas of mouse CD4+ T cell transcriptomes
Stubbington, M. J. T., Mahata, B., Svensson, V., Deonarine, A., Nissen, J. K., Betz, A. G., & Teichmann, S. A. (2015) · Biology Direct · doi:10.1186/s13062-015-0045-x · Cited by 92
Nuclear Receptor NR4A2 Orchestrates Th17 Cell-Mediated Autoimmune Inflammation via IL-21 Signalling
Raveney, B. J. E., Oki, S., & Yamamura, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056595 · Cited by 89
Yamashita, T., Iwakura, T., Matsui, K., Kawaguchi, H., Obana, M., Hayama, A., Maeda, M., Izumi, Y., Komuro, I., Ohsugi, Y., et al. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr148 · Cited by 90
Tryptophan Catabolism and Cancer Immunotherapy Targeting IDO Mediated Immune Suppression
Amobi, A. E., Qian, F., Lugade, A. A., & Odunsi, K. O. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-67577-0_9 · Cited by 90
Chen, Y., Jeffery, H. C., Hunter, S., Bhogal, R. H., Birtwistle, J., Braitch, M. K., Roberts, S., Ming, M., Hannah, J., Thomas, C., et al. (2016) · Hepatology · doi:10.1002/hep.28517 · Cited by 89
Transcriptional and epigenetic networks of helper T and innate lymphoid cells
Shih, H., Sciumè, G., Poholek, A. C., Vahedi, G., Hirahara, K., Villarino, A. V., Bonelli, M. M., Bosselut, R., Kanno, Y., Muljo, S. A., et al. (2014) · Immunological Reviews · doi:10.1111/imr.12208 · Cited by 91
Qiu, J., & Zhou, L. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0393-5 · Cited by 94
Role of the xenobiotic receptor in inflammatory bowel disease
Arsenescu, R. I., Arsenescu, V., Zhong, J., Nasser, M. S., Melinte, R., Dingle, C. R. W., Swanson, H. I., & de Villiers, W. J. S. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21463 · Cited by 88
Regulating inflammation with microbial metabolites
Marsland, B. J. (2016) · Nature Medicine · doi:10.1038/nm.4117 · Cited by 87
Ogando, J., Tardáguila, M., Díaz-Alderete, A., Usategui, A., Miranda-Ramos, V., Martínez-Herrera, D. J., de la Fuente, L., García-León, M. J., Moreno, M. C., Escudero, S. S., et al. (2016) · Scientific Reports · doi:10.1038/srep20223 · Cited by 90
Alcohol as friend or foe in autoimmune diseases: a role for gut microbiome?
Caslin, B., Mohler, K., Thiagarajan, S., & Melamed, E. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1916278 · Cited by 89
Role of IL-22 in Microbial Host Defense
Eidenschenk, C., Rutz, S., Liesenfeld, O., & Ouyang, W. (2014) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-43492-5_10 · Cited by 93
Microbiotal influence on T cell subset development
Atarashi, K., Umesaki, Y., & Honda, K. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.010 · Cited by 87
Xenobiotic-Activated Receptors: From Transcription to Drug Metabolism to Disease
Ma, Q. (2008) · Chemical Research in Toxicology · doi:10.1021/tx800156s · Cited by 87
Oxidative Stress and Treg and Th17 Dysfunction in Systemic Lupus Erythematosus
Yang, J. Y., Yang, X., Zou, H., & Li, M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/2526174 · Cited by 89
Wang, X., Yan, H., Zhao, L., Hao, Y., Guo, H., & Ren, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171721 · Cited by 85
Immunoregulation by the gut microbiota
Nishio, J., & Honda, K. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0993-6 · Cited by 87
Murray, I. A., Gowda, K., DiNatale, B. C., Flaveny, C. A., Chiaro, C. R., Lin, J.-M., Sharma, A. K., Amin, S., & Perdew, G. H. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100045h · Cited by 84
The aryl hydrocarbon receptor in inflammatory bowel disease
Monteleone, I., MacDonald, T. T., Pallone, F., & Monteleone, G. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328352ad69 · Cited by 85
CYP1A1 Enzymatic Activity Influences Skin Inflammation Via Regulation of the AHR Pathway
Kyoreva, M., Li, Y., Hoosenally, M., Hardman, J. A., Morrison, K., Tosi, I., Tolaini, M., Barinaga, G., Stockinger, B., Mrowietz, U., et al. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.11.024 · Cited by 84
Self-citationThe intestinal immune system and gut barrier function in obesity and ageing
Shemtov, S. J., Emani, R., Bielska, O., Covarrubias, A. J., Verdin, E. M., Andersen, J. K., & Winer, D. A. (2022) · FEBS Journal · doi:10.1111/febs.16558 · Cited by 86
Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders
Liu, M., Nieuwdorp, M., de Vos, W. M., & Rampanelli, E. (2022) · Metabolites · doi:10.3390/metabo12090834 · Cited by 86
Thymic and Peripheral Differentiation of Regulatory T Cells
Lee, H.-M., Bautista, J. L., & Hsieh, C. (2011) · Advances in immunology · doi:10.1016/b978-0-12-387827-4.00002-4 · Cited by 86
Wang, C., Ye, Z., Kijlstra, A., Zhou, Y.-J., & Yang, P. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12352 · Cited by 86
The molecular basis of nutritional intervention in multiple sclerosis: A narrative review
Riccio, P. (2011) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2011.06.006 · Cited by 86
Air pollution as a determinant of rheumatoid arthritis
Sigaux, J., Biton, J., André, E., Semerano, L., & Boissier, M. (2018) · Joint Bone Spine · doi:10.1016/j.jbspin.2018.03.001 · Cited by 88
Harrill, J. A., Hukkanen, R. R., Lawson, M., Martin, G., Gilger, B., Soldatow, V., LeCluyse, E. L., Budinsky, R. A., Rowlands, J. C., & Thomas, R. S. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.06.024 · Cited by 83
β-Catenin/TCF-1 Pathway in T Cell Development and Differentiation
Ma, J., Wang, R., Fang, X., & Sun, Z. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9367-y · Cited by 83
Commensal gut flora and brain autoimmunity: a love or hate affair?
Berer, K., & Krishnamoorthy, G. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0949-9 · Cited by 82
Metadata
- Authors
- Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B.
- Affiliations
- National Institute for Medical Research (GB)
- Essen University Hospital (DE)
- Ludwig Cancer Research (BE)
- Corresponding author
- Stockinger, Brigitta
- ORCID
- Venue
- Nature
- Published
- 2008-03-23
- Volume
- 453
- Issue
- 7191
- Pages
- 106-109
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1993003564
- Cited by
- 1,634
- References
- 31
- Citations by year
- 2026: 33 · 2025: 44 · 2024: 49 · 2023: 54 · 2022: 87 · 2021: 94 · 2020: 96 · 2019: 90 · 2018: 96 · 2017: 93 · 2016: 96 · 2015: 82 · 2014: 114 · 2013: 107 · 2012: 118
- FWCI
- 52.43
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HZI (Helmholtz Centre for Infection Research) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- University of Leicester
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- aryl hydrocarbon receptor, Th17 cells, autoimmunity, environmental toxins, IL-22, experimental autoimmune encephalitis, multiple sclerosis, regulatory T cells, CD4+ T cells, immunomodulation, AhR ligands, dioxins, IL-17
- MeSH terms
- Interleukin-22, Animals, Cell Differentiation, Cells, Cultured, Encephalomyelitis, Autoimmune, Experimental, Environmental Exposure, Environmental Pollutants, T-Lymphocytes, Helper-Inducer, Humans, Interleukins, Ligands, Mice, Inbred C57BL, Transduction, Genetic, Hazardous Substances, Autoimmunity, Receptors, Aryl Hydrocarbon, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review